Cargando…
Borneol Is a TRPM8 Agonist that Increases Ocular Surface Wetness
Borneol is a compound widely used in ophthalmic preparations in China. Little is known about its exact role in treating eye diseases. Here we report that transient receptor potential melastatin 8 (TRPM8) channel is a pharmacological target of borneol and mediates its therapeutic effect in the eyes....
Autores principales: | Chen, Gui-Lan, Lei, Ming, Zhou, Lu-Ping, Zeng, Bo, Zou, Fangdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957794/ https://www.ncbi.nlm.nih.gov/pubmed/27448228 http://dx.doi.org/10.1371/journal.pone.0158868 |
Ejemplares similares
-
TRPM8-regulated calcium mobilization plays a critical role in synergistic chemosensitization of Borneol on Doxorubicin
por: Lai, Haoqiang, et al.
Publicado: (2020) -
Topical TRPM8 Agonist for Relieving Neuropathic Ocular Pain in Patients with Dry Eye: A Pilot Study
por: Yoon, Hyeon Jeong, et al.
Publicado: (2021) -
A novel TRPM8 agonist relieves dry eye discomfort
por: Yang, Jee Myung, et al.
Publicado: (2017) -
Definition of two agonist types at the mammalian cold-activated channel TRPM8
por: Janssens, Annelies, et al.
Publicado: (2016) -
Investigation of borneols sold in Taiwan by chiral gas chromatography
por: Ho, Tsung-Jung, et al.
Publicado: (2016)